[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Venous Thromboembolism (VTE) Devices Market Growth 2023-2029

March 2023 | 118 pages | ID: G58A306C7154EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual

LPI (LP Information)' newest research report, the “Venous Thromboembolism (VTE) Devices Industry Forecast” looks at past sales and reviews total world Venous Thromboembolism (VTE) Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Venous Thromboembolism (VTE) Devices sales for 2023 through 2029. With Venous Thromboembolism (VTE) Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Venous Thromboembolism (VTE) Devices industry.

This Insight Report provides a comprehensive analysis of the global Venous Thromboembolism (VTE) Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Venous Thromboembolism (VTE) Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Venous Thromboembolism (VTE) Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Venous Thromboembolism (VTE) Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Venous Thromboembolism (VTE) Devices.

The global Venous Thromboembolism (VTE) Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Venous Thromboembolism (VTE) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Venous Thromboembolism (VTE) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Venous Thromboembolism (VTE) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Venous Thromboembolism (VTE) Devices players cover ArjoHuntleigh, Armetheon, Bayer, Bio Compression Systems, Boehringer Ingelheim, Breg, Bristol-Myers Squibb, Cardinal Health and Currie Medical Specialties, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Venous Thromboembolism (VTE) Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Deep Vein Thrombosis(DVT)
  • Pulmonary Embolism(PE)
  • Others
Segmentation by application
  • Hospitals
  • Surgical Centers
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • ArjoHuntleigh
  • Armetheon
  • Bayer
  • Bio Compression Systems
  • Boehringer Ingelheim
  • Breg
  • Bristol-Myers Squibb
  • Cardinal Health
  • Currie Medical Specialties
  • Daiichi-Sankyo
  • Devon Medical Products
  • DJO
  • Janssen
  • Mego Afek AC LTD
  • Normatec
  • Pfizer
  • Portola Pharmaceuticals
  • ThermoTek USA
  • Zimmer Biomet
Key Questions Addressed in this Report

What is the 10-year outlook for the global Venous Thromboembolism (VTE) Devices market?

What factors are driving Venous Thromboembolism (VTE) Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Venous Thromboembolism (VTE) Devices market opportunities vary by end market size?

How does Venous Thromboembolism (VTE) Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Venous Thromboembolism (VTE) Devices Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Venous Thromboembolism (VTE) Devices by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Venous Thromboembolism (VTE) Devices by Country/Region, 2018, 2022 & 2029
2.2 Venous Thromboembolism (VTE) Devices Segment by Type
  2.2.1 Deep Vein Thrombosis(DVT)
  2.2.2 Pulmonary Embolism(PE)
  2.2.3 Others
2.3 Venous Thromboembolism (VTE) Devices Sales by Type
  2.3.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
  2.3.2 Global Venous Thromboembolism (VTE) Devices Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Venous Thromboembolism (VTE) Devices Sale Price by Type (2018-2023)
2.4 Venous Thromboembolism (VTE) Devices Segment by Application
  2.4.1 Hospitals
  2.4.2 Surgical Centers
  2.4.3 Other
2.5 Venous Thromboembolism (VTE) Devices Sales by Application
  2.5.1 Global Venous Thromboembolism (VTE) Devices Sale Market Share by Application (2018-2023)
  2.5.2 Global Venous Thromboembolism (VTE) Devices Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Venous Thromboembolism (VTE) Devices Sale Price by Application (2018-2023)

3 GLOBAL VENOUS THROMBOEMBOLISM (VTE) DEVICES BY COMPANY

3.1 Global Venous Thromboembolism (VTE) Devices Breakdown Data by Company
  3.1.1 Global Venous Thromboembolism (VTE) Devices Annual Sales by Company (2018-2023)
  3.1.2 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Company (2018-2023)
3.2 Global Venous Thromboembolism (VTE) Devices Annual Revenue by Company (2018-2023)
  3.2.1 Global Venous Thromboembolism (VTE) Devices Revenue by Company (2018-2023)
  3.2.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Company (2018-2023)
3.3 Global Venous Thromboembolism (VTE) Devices Sale Price by Company
3.4 Key Manufacturers Venous Thromboembolism (VTE) Devices Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Venous Thromboembolism (VTE) Devices Product Location Distribution
  3.4.2 Players Venous Thromboembolism (VTE) Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR VENOUS THROMBOEMBOLISM (VTE) DEVICES BY GEOGRAPHIC REGION

4.1 World Historic Venous Thromboembolism (VTE) Devices Market Size by Geographic Region (2018-2023)
  4.1.1 Global Venous Thromboembolism (VTE) Devices Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Venous Thromboembolism (VTE) Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Venous Thromboembolism (VTE) Devices Market Size by Country/Region (2018-2023)
  4.2.1 Global Venous Thromboembolism (VTE) Devices Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Venous Thromboembolism (VTE) Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Venous Thromboembolism (VTE) Devices Sales Growth
4.4 APAC Venous Thromboembolism (VTE) Devices Sales Growth
4.5 Europe Venous Thromboembolism (VTE) Devices Sales Growth
4.6 Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Growth

5 AMERICAS

5.1 Americas Venous Thromboembolism (VTE) Devices Sales by Country
  5.1.1 Americas Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023)
  5.1.2 Americas Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023)
5.2 Americas Venous Thromboembolism (VTE) Devices Sales by Type
5.3 Americas Venous Thromboembolism (VTE) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Venous Thromboembolism (VTE) Devices Sales by Region
  6.1.1 APAC Venous Thromboembolism (VTE) Devices Sales by Region (2018-2023)
  6.1.2 APAC Venous Thromboembolism (VTE) Devices Revenue by Region (2018-2023)
6.2 APAC Venous Thromboembolism (VTE) Devices Sales by Type
6.3 APAC Venous Thromboembolism (VTE) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Venous Thromboembolism (VTE) Devices by Country
  7.1.1 Europe Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023)
  7.1.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023)
7.2 Europe Venous Thromboembolism (VTE) Devices Sales by Type
7.3 Europe Venous Thromboembolism (VTE) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Venous Thromboembolism (VTE) Devices by Country
  8.1.1 Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Type
8.3 Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Venous Thromboembolism (VTE) Devices
10.3 Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
10.4 Industry Chain Structure of Venous Thromboembolism (VTE) Devices

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Venous Thromboembolism (VTE) Devices Distributors
11.3 Venous Thromboembolism (VTE) Devices Customer

12 WORLD FORECAST REVIEW FOR VENOUS THROMBOEMBOLISM (VTE) DEVICES BY GEOGRAPHIC REGION

12.1 Global Venous Thromboembolism (VTE) Devices Market Size Forecast by Region
  12.1.1 Global Venous Thromboembolism (VTE) Devices Forecast by Region (2024-2029)
  12.1.2 Global Venous Thromboembolism (VTE) Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Venous Thromboembolism (VTE) Devices Forecast by Type
12.7 Global Venous Thromboembolism (VTE) Devices Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 ArjoHuntleigh
  13.1.1 ArjoHuntleigh Company Information
  13.1.2 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 ArjoHuntleigh Main Business Overview
  13.1.5 ArjoHuntleigh Latest Developments
13.2 Armetheon
  13.2.1 Armetheon Company Information
  13.2.2 Armetheon Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Armetheon Main Business Overview
  13.2.5 Armetheon Latest Developments
13.3 Bayer
  13.3.1 Bayer Company Information
  13.3.2 Bayer Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Bayer Main Business Overview
  13.3.5 Bayer Latest Developments
13.4 Bio Compression Systems
  13.4.1 Bio Compression Systems Company Information
  13.4.2 Bio Compression Systems Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Bio Compression Systems Main Business Overview
  13.4.5 Bio Compression Systems Latest Developments
13.5 Boehringer Ingelheim
  13.5.1 Boehringer Ingelheim Company Information
  13.5.2 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Boehringer Ingelheim Main Business Overview
  13.5.5 Boehringer Ingelheim Latest Developments
13.6 Breg
  13.6.1 Breg Company Information
  13.6.2 Breg Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Breg Main Business Overview
  13.6.5 Breg Latest Developments
13.7 Bristol-Myers Squibb
  13.7.1 Bristol-Myers Squibb Company Information
  13.7.2 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.7.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Bristol-Myers Squibb Main Business Overview
  13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Cardinal Health
  13.8.1 Cardinal Health Company Information
  13.8.2 Cardinal Health Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Cardinal Health Main Business Overview
  13.8.5 Cardinal Health Latest Developments
13.9 Currie Medical Specialties
  13.9.1 Currie Medical Specialties Company Information
  13.9.2 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Currie Medical Specialties Main Business Overview
  13.9.5 Currie Medical Specialties Latest Developments
13.10 Daiichi-Sankyo
  13.10.1 Daiichi-Sankyo Company Information
  13.10.2 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Daiichi-Sankyo Main Business Overview
  13.10.5 Daiichi-Sankyo Latest Developments
13.11 Devon Medical Products
  13.11.1 Devon Medical Products Company Information
  13.11.2 Devon Medical Products Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Devon Medical Products Main Business Overview
  13.11.5 Devon Medical Products Latest Developments
13.12 DJO
  13.12.1 DJO Company Information
  13.12.2 DJO Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 DJO Main Business Overview
  13.12.5 DJO Latest Developments
13.13 Janssen
  13.13.1 Janssen Company Information
  13.13.2 Janssen Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Janssen Main Business Overview
  13.13.5 Janssen Latest Developments
13.14 Mego Afek AC LTD
  13.14.1 Mego Afek AC LTD Company Information
  13.14.2 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Mego Afek AC LTD Main Business Overview
  13.14.5 Mego Afek AC LTD Latest Developments
13.15 Normatec
  13.15.1 Normatec Company Information
  13.15.2 Normatec Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Normatec Main Business Overview
  13.15.5 Normatec Latest Developments
13.16 Pfizer
  13.16.1 Pfizer Company Information
  13.16.2 Pfizer Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Pfizer Main Business Overview
  13.16.5 Pfizer Latest Developments
13.17 Portola Pharmaceuticals
  13.17.1 Portola Pharmaceuticals Company Information
  13.17.2 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Portola Pharmaceuticals Main Business Overview
  13.17.5 Portola Pharmaceuticals Latest Developments
13.18 ThermoTek USA
  13.18.1 ThermoTek USA Company Information
  13.18.2 ThermoTek USA Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 ThermoTek USA Main Business Overview
  13.18.5 ThermoTek USA Latest Developments
13.19 Zimmer Biomet
  13.19.1 Zimmer Biomet Company Information
  13.19.2 Zimmer Biomet Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
  13.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.19.4 Zimmer Biomet Main Business Overview
  13.19.5 Zimmer Biomet Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Venous Thromboembolism (VTE) Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Venous Thromboembolism (VTE) Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Deep Vein Thrombosis(DVT)
Table 4. Major Players of Pulmonary Embolism(PE)
Table 5. Major Players of Others
Table 6. Global Venous Thromboembolism (VTE) Devices Sales by Type (2018-2023) & (K Units)
Table 7. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
Table 8. Global Venous Thromboembolism (VTE) Devices Revenue by Type (2018-2023) & ($ million)
Table 9. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2018-2023)
Table 10. Global Venous Thromboembolism (VTE) Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Venous Thromboembolism (VTE) Devices Sales by Application (2018-2023) & (K Units)
Table 12. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2018-2023)
Table 13. Global Venous Thromboembolism (VTE) Devices Revenue by Application (2018-2023)
Table 14. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2018-2023)
Table 15. Global Venous Thromboembolism (VTE) Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Venous Thromboembolism (VTE) Devices Sales by Company (2018-2023) & (K Units)
Table 17. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Company (2018-2023)
Table 18. Global Venous Thromboembolism (VTE) Devices Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Company (2018-2023)
Table 20. Global Venous Thromboembolism (VTE) Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Venous Thromboembolism (VTE) Devices Producing Area Distribution and Sales Area
Table 22. Players Venous Thromboembolism (VTE) Devices Products Offered
Table 23. Venous Thromboembolism (VTE) Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Venous Thromboembolism (VTE) Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Venous Thromboembolism (VTE) Devices Sales Market Share Geographic Region (2018-2023)
Table 28. Global Venous Thromboembolism (VTE) Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Venous Thromboembolism (VTE) Devices Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Country/Region (2018-2023)
Table 32. Global Venous Thromboembolism (VTE) Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023) & (K Units)
Table 35. Americas Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2018-2023)
Table 36. Americas Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2018-2023)
Table 38. Americas Venous Thromboembolism (VTE) Devices Sales by Type (2018-2023) & (K Units)
Table 39. Americas Venous Thromboembolism (VTE) Devices Sales by Application (2018-2023) & (K Units)
Table 40. APAC Venous Thromboembolism (VTE) Devices Sales by Region (2018-2023) & (K Units)
Table 41. APAC Venous Thromboembolism (VTE) Devices Sales Market Share by Region (2018-2023)
Table 42. APAC Venous Thromboembolism (VTE) Devices Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Venous Thromboembolism (VTE) Devices Revenue Market Share by Region (2018-2023)
Table 44. APAC Venous Thromboembolism (VTE) Devices Sales by Type (2018-2023) & (K Units)
Table 45. APAC Venous Thromboembolism (VTE) Devices Sales by Application (2018-2023) & (K Units)
Table 46. Europe Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023) & (K Units)
Table 47. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2018-2023)
Table 48. Europe Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2018-2023)
Table 50. Europe Venous Thromboembolism (VTE) Devices Sales by Type (2018-2023) & (K Units)
Table 51. Europe Venous Thromboembolism (VTE) Devices Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Venous Thromboembolism (VTE) Devices
Table 59. Key Market Challenges & Risks of Venous Thromboembolism (VTE) Devices
Table 60. Key Industry Trends of Venous Thromboembolism (VTE) Devices
Table 61. Venous Thromboembolism (VTE) Devices Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Venous Thromboembolism (VTE) Devices Distributors List
Table 64. Venous Thromboembolism (VTE) Devices Customer List
Table 65. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Venous Thromboembolism (VTE) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Venous Thromboembolism (VTE) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Venous Thromboembolism (VTE) Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Venous Thromboembolism (VTE) Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Venous Thromboembolism (VTE) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Venous Thromboembolism (VTE) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Venous Thromboembolism (VTE) Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Venous Thromboembolism (VTE) Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. ArjoHuntleigh Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 81. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. ArjoHuntleigh Main Business
Table 83. ArjoHuntleigh Latest Developments
Table 84. Armetheon Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Armetheon Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 86. Armetheon Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Armetheon Main Business
Table 88. Armetheon Latest Developments
Table 89. Bayer Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. Bayer Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 91. Bayer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Bayer Main Business
Table 93. Bayer Latest Developments
Table 94. Bio Compression Systems Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Bio Compression Systems Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 96. Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Bio Compression Systems Main Business
Table 98. Bio Compression Systems Latest Developments
Table 99. Boehringer Ingelheim Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 101. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Boehringer Ingelheim Main Business
Table 103. Boehringer Ingelheim Latest Developments
Table 104. Breg Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Breg Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 106. Breg Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Breg Main Business
Table 108. Breg Latest Developments
Table 109. Bristol-Myers Squibb Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 111. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bristol-Myers Squibb Main Business
Table 113. Bristol-Myers Squibb Latest Developments
Table 114. Cardinal Health Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Cardinal Health Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 116. Cardinal Health Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Cardinal Health Main Business
Table 118. Cardinal Health Latest Developments
Table 119. Currie Medical Specialties Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 121. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Currie Medical Specialties Main Business
Table 123. Currie Medical Specialties Latest Developments
Table 124. Daiichi-Sankyo Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 125. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 126. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Daiichi-Sankyo Main Business
Table 128. Daiichi-Sankyo Latest Developments
Table 129. Devon Medical Products Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 130. Devon Medical Products Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 131. Devon Medical Products Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Devon Medical Products Main Business
Table 133. Devon Medical Products Latest Developments
Table 134. DJO Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 135. DJO Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 136. DJO Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. DJO Main Business
Table 138. DJO Latest Developments
Table 139. Janssen Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 140. Janssen Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 141. Janssen Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Janssen Main Business
Table 143. Janssen Latest Developments
Table 144. Mego Afek AC LTD Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 145. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 146. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Mego Afek AC LTD Main Business
Table 148. Mego Afek AC LTD Latest Developments
Table 149. Normatec Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 150. Normatec Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 151. Normatec Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Normatec Main Business
Table 153. Normatec Latest Developments
Table 154. Pfizer Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 155. Pfizer Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 156. Pfizer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Pfizer Main Business
Table 158. Pfizer Latest Developments
Table 159. Portola Pharmaceuticals Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 160. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 161. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Portola Pharmaceuticals Main Business
Table 163. Portola Pharmaceuticals Latest Developments
Table 164. ThermoTek USA Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 165. ThermoTek USA Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 166. ThermoTek USA Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. ThermoTek USA Main Business
Table 168. ThermoTek USA Latest Developments
Table 169. Zimmer Biomet Basic Information, Venous Thromboembolism (VTE) Devices Manufacturing Base, Sales Area and Its Competitors
Table 170. Zimmer Biomet Venous Thromboembolism (VTE) Devices Product Portfolios and Specifications
Table 171. Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Zimmer Biomet Main Business
Table 173. Zimmer Biomet Latest Developments

LIST OF FIGURES

Figure 1. Picture of Venous Thromboembolism (VTE) Devices
Figure 2. Venous Thromboembolism (VTE) Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Venous Thromboembolism (VTE) Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Venous Thromboembolism (VTE) Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Venous Thromboembolism (VTE) Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Deep Vein Thrombosis(DVT)
Figure 10. Product Picture of Pulmonary Embolism(PE)
Figure 11. Product Picture of Others
Figure 12. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type in 2022
Figure 13. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2018-2023)
Figure 14. Venous Thromboembolism (VTE) Devices Consumed in Hospitals
Figure 15. Global Venous Thromboembolism (VTE) Devices Market: Hospitals (2018-2023) & (K Units)
Figure 16. Venous Thromboembolism (VTE) Devices Consumed in Surgical Centers
Figure 17. Global Venous Thromboembolism (VTE) Devices Market: Surgical Centers (2018-2023) & (K Units)
Figure 18. Venous Thromboembolism (VTE) Devices Consumed in Other
Figure 19. Global Venous Thromboembolism (VTE) Devices Market: Other (2018-2023) & (K Units)
Figure 20. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2022)
Figure 21. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application in 2022
Figure 22. Venous Thromboembolism (VTE) Devices Sales Market by Company in 2022 (K Units)
Figure 23. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Company in 2022
Figure 24. Venous Thromboembolism (VTE) Devices Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Company in 2022
Figure 26. Global Venous Thromboembolism (VTE) Devices Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Venous Thromboembolism (VTE) Devices Sales 2018-2023 (K Units)
Figure 29. Americas Venous Thromboembolism (VTE) Devices Revenue 2018-2023 ($ Millions)
Figure 30. APAC Venous Thromboembolism (VTE) Devices Sales 2018-2023 (K Units)
Figure 31. APAC Venous Thromboembolism (VTE) Devices Revenue 2018-2023 ($ Millions)
Figure 32. Europe Venous Thromboembolism (VTE) Devices Sales 2018-2023 (K Units)
Figure 33. Europe Venous Thromboembolism (VTE) Devices Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue 2018-2023 ($ Millions)
Figure 36. Americas Venous Thromboembolism (VTE) Devices Sales Market Share by Country in 2022
Figure 37. Americas Venous Thromboembolism (VTE) Devices Revenue Market Share by Country in 2022
Figure 38. Americas Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
Figure 39. Americas Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2018-2023)
Figure 40. United States Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Venous Thromboembolism (VTE) Devices Sales Market Share by Region in 2022
Figure 45. APAC Venous Thromboembolism (VTE) Devices Revenue Market Share by Regions in 2022
Figure 46. APAC Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
Figure 47. APAC Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2018-2023)
Figure 48. China Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Country in 2022
Figure 56. Europe Venous Thromboembolism (VTE) Devices Revenue Market Share by Country in 2022
Figure 57. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
Figure 58. Europe Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2018-2023)
Figure 59. Germany Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Venous Thromboembolism (VTE) Devices Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2018-2023)
Figure 68. Egypt Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Venous Thromboembolism (VTE) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Venous Thromboembolism (VTE) Devices in 2022
Figure 74. Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
Figure 75. Industry Chain Structure of Venous Thromboembolism (VTE) Devices
Figure 76. Channels of Distribution
Figure 77. Global Venous Thromboembolism (VTE) Devices Sales Market Forecast by Region (2024-2029)
Figure 78. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Venous Thromboembolism (VTE) Devices Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Venous Thromboembolism (VTE) Devices Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Venous Thromboembolism (VTE) Devices Revenue Market Share Forecast by Application (2024-2029)


More Publications